Stock Events

Stock Events

Search...

Lineage Cell Therapeutics (LCTX.TA) Q3 2024 Earnings

8AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-17.04

-11.37

-5.7

-0.03

Details

Expected EPS

-17.042489999999997

Actual EPS

-11.361659999999999

Surprise EPS

5.68

Surprise Percent

+33.33%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -11.361659999999999 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.